Related Experiment Video
Updated: Aug 11, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
[Diagnostic and therapeutic problems in primary antiphospholipid syndrome]
I Obroniecka1, A Olszowska, A Raczka
1Klinika Nefrologii ze Stacja Dializ Instytutu Medycyny Wewnetrznej Centralnego Szpitala Klinicznego WAM w Warszawie.
Primary antiphospholipid syndrome presents significant clinical challenges, including recurrent fetal loss and blood clots. Management focuses on preventing complications in future pregnancies.
Area of Science:
- Reproductive immunology
- Hematology
- Autoimmune disorders
Background:
- Primary antiphospholipid syndrome (APS) is an autoimmune condition characterized by specific antibodies and clinical events.
- Recurrent fetal loss, thrombocytopenia, and thrombo-embolic disorders are key manifestations of APS.
Observation:
- The case study details a woman with primary APS, presenting with recurrent fetal losses, low platelet count (thrombocytopenia), and blood clots (thrombo-embolic disorders).
- Diagnostic workup included identifying lupus anticoagulant factor and high antiphospholipid antibodies (aPL).
- Systemic lupus erythematosus (SLE) was excluded through clinical history, physical examination, laboratory tests, and kidney biopsy.
Findings:
- The patient's presentation confirmed primary antiphospholipid syndrome, distinct from SLE.
- The diagnostic criteria for APS were met, highlighting the complexity of its clinical manifestations.
Implications:
- Understanding the clinical profile of primary APS is crucial for accurate diagnosis and management.
- Prophylactic strategies are essential to mitigate pregnancy complications in women with APS.
- Further research into APS pathogenesis and treatment is warranted.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care